公司資料
DURECT Corporation 股價、新聞與催化劑
- 股票代碼:
- DRRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for DRRX.
公司概覽
業務概覽
DURECT was a specialty pharmaceutical company focused on pain, liver disease, and drug-delivery programs before its restructuring and public-market decline. Its story centered on trying to commercialize niche assets.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, DURECT sat in specialty biopharma.
商業模式特徵
The business depended on product development, delivery technology, and the chance to create value from a narrow portfolio.
生技產業定位
DURECT belongs to the historical specialty-pharma set rather than the current live public-company universe.
未來催化劑
- DURECT’s catalysts are legacy and transaction-related, with any remaining asset-resolution or capital-update milestone doing the work. The company is no longer a live pipeline name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。